Cel-Sci (CVM) Live Share Price, Invest From India

Cel-Sci Stock Performance

as on October 15, 2026 at 2:16 pm IST

Day's Low
Day's High
$1.68
Day's Price Range
$1.75
$1.71
1.75%
Downside
2.34%
Upside
52 Week's Low
52 Week's High
$0.89
52-Week Price Range
$10.24
$1.71
47.95%
Downside
498.82%
Upside

Cel-Sci share price movements today

Previous Close: $1.75
Open: $1.75
Volume: 308.5K
Market Cap: $30.8M
Day's Low - High: $1.68 - $1.75
52 Week Low - High: $0.89 - $10.24

Cel-Sci Historical Returns

1 Month Return: + 15.54 %
3 Month Return: + 48.7 %
1 Year Return: -83.09 %
3 Year Return: -95 %
5 Year Return: -99.45 %

Cel-Sci Stock Fundamentals & Key Indicators

Check Cel-Sci market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$30.8M

EPS (TTM)

-2.58

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.68

Industry PE ratio

-2.42

PEG Ratio

-0.00

EBITDA

-18.5M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-202.14%

Cel-Sci vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cel-Sci with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Cel-Sci	Buy	$30.8M	-99.45%	-0.68	0.00%	0.00%
Moderna	Neutral	$86.3B	-30.20%	-28.20	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$123.0B	174.25%	28.02	86.04%	0.00%
Regeneron	Buy	$78.5B	40.69%	17.83	84.86%	0.49%

Stock Returns calculator for Cel-Sci Stock including INR - Dollar returns

The Cel-Sci stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Cel-Sci investment value today

Current value as on today

₹18,309

Returns

-₹81,691

(-81.69%)

Returns from Cel-Sci Stock

-₹83,086 (-83.09%)

Dollar Impact

₹1,396 (+1.4%)

Analyst Recommendation on Cel-Sci Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for Cel-Sci. Average target price of $12.5

Cel-Sci Share Price Target

Get share price movements and forecasts by analysts on Cel-Sci.

What analysts predicted

86.32%UPSIDE

Target Price

$12.5

Current Price

$1.71

Analyzed by

5 Analysts

Target

$12.50

Cel-Sci target price $12.5, a slight upside of 86.32% compared to current price of $1.71. According to 5 analysts rating.

Indian Investors' Interest in Cel-Sci Stock

Search interest for Cel-Sci Stock has increased by 26% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 15, 2026 to October 15, 2026

Change:26% versus previous 30 day period

Cel-Sci Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	-	0	0	-4	0	0	-3	0	0
Operating Income	-7	-6	-6	-6	-6	-5	-6	-5	-5	-5
EBITDA	-6	-5	-5	-5	-5	-4	-5	-4	-4	-4
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-7	-6	-6	-7	-6	-5	-6	-5	-5	-5
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-7	-6	-6	-7	-6	-5	-6	-5	-5	-5
Net Profit Margin	0.00%	0.00%	-16.66%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Cel-Sci Annual Profit & Loss

All numbers in Millions USD

	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Total Revenue	0	0	0	0	-	-	-	-	-
Gross Profit	0	0	0	-17	-	-	-22	-3	-15
Operating Income	-21	-16	-20	-28	-36	-36	-31	-26	-24
EBITDA	-20	-16	-19	-26	-32	-31	-27	-22	-20
Interest Expense	4	-	1	1	1	1	0	0	0
Depreciation	0	0	0	2	2	3	3	3	3
Income Before Tax	-14	-31	-22	-30	-36	-36	-32	-26	-25
Income Tax Expense	-	-	-	-	-	-	-	-	-
Net Income	-14	-31	-24	-30	-36	-36	-32	-26	-25
Net Profit Margin	-817.13%	97.71%	97.26%	96.81%	0.00%	0.00%	0.00%	0.00%	0.00%

Cel-Sci Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-7	-6	-6	-7	-6	-5	-6	-5	-5	-5
Operating Cash Flow	-4	-4	-4	-4	-4	-3	-4	-4	-4	-4
Investing Cash Flow	-	0	0	0	-	-	0	-	-	-
Financing Cash Flow	6	0	9	4	1	3	13	0	0	8
Change in Cash	2	-4	4	0	-2	0	9	-4	-4	4

Cel-Sci Annual Cash Flow

All numbers in Millions USD

	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Net Income	-14	-31	-22	-30	-36	-36	-32	-26	-25
Operating Cash Flow	-13	-13	-16	-15	-18	-18	-22	-18	-17
Investing Cash Flow	0	0	0	-2	-15	5	0	0	0
Financing Cash Flow	13	21	14	25	54	0	4	19	23
Change in Cash	0	7	-1	7	20	-13	-18	0	6

Global Institutional Holdings in Cel-Sci

Check out the Institutions with significant holdings in Cel-Sci.

Funds	Holdings
Vanguard	3.09%
VANGUARD INDEX FUNDS	1.34%
Fidelity Concord Street Trust	0.37%
Bridgeway Funds, Inc.	0.04%
Bridgeway	0.04%

See all

Insights on Cel-Sci

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, CVM stock has moved up by 15.5%
NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 130.2% return, outperforming this stock by 225.2%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 716.4% return, outperforming this stock by 799.5%

About Cel-Sci

CEL-SCI Corporation (CVM) focuses on the research and development of immune-based therapies to combat cancer and various infectious diseases. Its flagship immunotherapy candidate, Multikine, is currently undergoing Phase III clinical trials for the treatment of head and neck cancer. The company also develops and holds the patent for its preclinical Ligand Epitope Antigen Presentation System (LEAPS), an innovative T-cell modulation technology. This system is designed to stimulate the human immune system to fight a broad range of conditions, including bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and various cancers. CEL-SCI's pipeline further includes LEAPS-H1N1-DC, along with LEAPS COV-19, an experimental therapy targeting the COVID-19 coronavirus. Additionally, the company is advancing CEL-2000 and CEL-4000 as potential treatments for rheumatoid arthritis. In a collaborative effort, CEL-SCI has partnered with the University of Georgia's Center for Vaccines and Immunology to progress the LEAPS COVID-19 immunotherapy. Established in 1983, the company's headquarters are located in Vienna, Virginia.

Organisation	Cel-Sci
Headquarters	8229 Boone Boulevard, Vienna, VA, 22182, US
Industry	Biotechnology
CEO	Geert R. Kersten

Key Management of Cel-Sci

Name	Title
Mr. Geert R. Kersten Esq.	CEO, CAO,Treasurer and Director
Ms. Patricia B. Prichep	Chief Financial & Operations Officer, Compliance Officer & Corporate Secretary
Dr. Eyal Talor Ph.D.	Chief Scientific Officer
Mr. John Cipriano	Senior Vice President of Regulatory Affairs

FAQs

What is Cel-Sci share price today?

Cel-Sci share price today is $1.71 as on October 15, 2026 at 8:46 am IST at the close of the market. Cel-Sci share today touched a day high of $1.75 and a low of $1.68.

What is the 52 week high and 52 week low for Cel-Sci share?

Cel-Sci share touched a 52 week high of $10.24 on October 15, 2025 and a 52 week low of $0.89 on May 12, 2026. Cel-Sci stock price today i.e. October 15, 2026 at 8:46 am IST is closed at $1.71,which is 83.30% down from its 52 week high and 92.13% up from its 52 week low.

What is Cel-Sci's market capitalisation today?

Cel-Sci market capitalisation is $0.00T as on October 15, 2026 at 8:46 am IST.

How to invest in Cel-Sci Stock (CVM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cel-Sci on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Cel-Sci Stock (CVM) from India?

Indian investors can start investing in Cel-Sci (CVM) shares with as little as ₹95.05500030517578 or $1 (as of October 15, 2026 at 6:44 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹950.55 in Cel-Sci stock (as per the Rupee-Dollar exchange rate as on October 15, 2026 at 6:44 pm IST). Based on Cel-Sci share’s latest price of $1.71 as on October 15, 2026 at 8:46 am IST, you will get 5.8480 shares of Cel-Sci. Learn more about fractional shares .

What are the returns that Cel-Sci has given to Indian investors in the last 5 years?

Cel-Sci stock has given -99.45% share price returns and 27.65% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?